Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Nacionalni Institut Za Biologijo currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single action represents the entirety of the company's active prosecution presence. The workload is concentrated in the distinct art unit, which indicates a specific and narrow focus for the intellectual property currently under review by the patent office.
The prosecution of this action is being handled by 1 distinct examiner, DELEO, VICTORIA LYNN. As the busiest examiner for the portfolio, DELEO, VICTORIA LYNN is responsible for the pending action, which accounts for the total volume of the company's current pending matters. This relationship between the examiner and the portfolio means that the immediate patent outcomes are dependent on the findings of this individual.
For a portfolio with only 1 pending office action, there is no opportunity to compare examiner behaviors within the company's own data. The prosecution environment is centralized, with DELEO, VICTORIA LYNN serving as the point of contact for the Biotechnology & Pharmaceuticals filing. Practitioners must focus on the specific preferences of this examiner to navigate the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DELEO, VICTORIA LYNN | 1 | 41.4% | -44.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19479699 | PLANTS PRODUCING PROTEINS FOR PEST CONTROL | DELEO, VICTORIA LYNN | — |
| Art Unit | Apps |
|---|---|
| 1662 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19479699 | PLANTS PRODUCING PROTEINS FOR PEST CONTROL | DELEO, VICTORIA LYNN | 1662 | §101§103§112DP | Non-Final OA | — | Pending | Oct 28, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNacionalni Institut Za Biologijo has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Victoria Lynn Deleo has the most, with 1 of Nacionalni Institut Za Biologijo's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.